US Edition“Critical Non-Compliances”: the Anmat Removed the Habilitation to Eight Laboratories and Inhibited Two Other Laboratories
12 Articles
12 Articles
Two pharmaceutical companies were inhibited from operating because of “multiple critical breaches”, while eight other laboratories and drugstores lost their ability to function, according to the Government. The list of these casualties includes the Apollo laboratory, which exploded a decade ago in Rosario. With the replacement in the management of the National Food, Drug and Health Technology Administration (Anmat), decisions were reactivated th…
The National Administration of Medicines, Food and Medical Technology (ANMAT) inhibited the productive activities of two laboratories due to several critical non-compliances with the Good Pharmacovigilance and Manufacturing Practices. Through two communiqués, the ANMAT authorities announced that the activities of the firms Laboratorios Solkotal S.A. and Biotenko S.A. were disqualified. The first was due to non-compliances with the Good Manufactu…
The scientific-technical body suspended activities and revoked allotments. From the SAFyB, led by Marcelo Peretta, they asked the laboratories to comply with the law that requires the technical direction of a pharmacist or a biochemist. From the Argentine Union of Pharmaceuticals and Biochemists (SAFyB) they reacted to the decision of the National Administration of Medicines, Food and Medical Technology (ANMAT) that decided to close ten laborato…
The authorities seek that only establishments that comply with technical, professional and regulatory requirements are enabled
He also inhibited the Solkotal S.A. laboratory and discharged eight other establishments.
The National Administration of Medications, Food and Medical Technology (ANMAT) ordered on Monday the discharge of nine laboratories and drugstores operating in the country. The decision, based on the need to protect public health, was made after an audit of the Registry of Registration of Establishments that confirmed that none of these firms respected the...
Coverage Details
Bias Distribution
- 100% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
